Related Experiment Videos
Improved exercise myocardial perfusion during lidoflazine therapy
Angiology
|November 1, 1983
Summary
Lidoflazine, a calcium-channel blocker, improved exercise-induced myocardial perfusion in patients with severe angina. This synthetic drug therapy relieved chest pain and enhanced physical capacity.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Severe classic angina pectoris significantly impacts patients' quality of life.
- Calcium-channel blockers are a therapeutic class for managing ischemic heart conditions.
Purpose of the Study:
- To evaluate the effects of lidoflazine on myocardial perfusion in patients with severe angina.
- To assess lidoflazine's impact on exercise capacity and angina relief.
Main Methods:
- A single-blind study involving 6 patients with severe classic angina pectoris.
- Assessment of myocardial perfusion using thallium-201 stress scintigraphy during exercise.
- Monitoring of physical work capacity and angina symptoms.
Main Results:
- Lidoflazine administration improved myocardial perfusion during exercise.
- Patients experienced relief from angina symptoms.
- An increase in physical work capacity was observed.
Conclusions:
- Lidoflazine therapy demonstrates efficacy in improving myocardial perfusion in angina patients.
- Lidoflazine offers potential benefits for angina relief and enhanced exercise tolerance.